vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and TIMBERLAND BANCORP INC (TSBK). Click either name above to swap in a different company.

TIMBERLAND BANCORP INC is the larger business by last-quarter revenue ($21.7M vs $14.7M, roughly 1.5× IRIDEX CORP). On growth, TIMBERLAND BANCORP INC posted the faster year-over-year revenue change (10.4% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs 9.1%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Timberland Bancorp Inc is a U.S.-based bank holding company operating primarily across Washington state. It provides a full range of personal and commercial banking services including checking and savings accounts, residential and commercial mortgages, small business loans, and wealth management solutions for local retail and small to mid-sized business clients.

IRIX vs TSBK — Head-to-Head

Bigger by revenue
TSBK
TSBK
1.5× larger
TSBK
$21.7M
$14.7M
IRIX
Growing faster (revenue YoY)
TSBK
TSBK
+80.1% gap
TSBK
10.4%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
9.1%
TSBK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IRIX
IRIX
TSBK
TSBK
Revenue
$14.7M
$21.7M
Net Profit
$8.2M
Gross Margin
37.2%
Operating Margin
Net Margin
37.8%
Revenue YoY
-69.7%
10.4%
Net Profit YoY
19.8%
EPS (diluted)
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
TSBK
TSBK
Q4 25
$14.7M
$21.7M
Q3 25
$12.5M
$22.5M
Q2 25
$13.6M
$20.5M
Q1 25
$11.9M
$19.9M
Q4 24
$12.7M
$19.7M
Q3 24
$11.6M
$19.5M
Q2 24
$12.6M
$18.8M
Q1 24
$11.8M
$18.3M
Net Profit
IRIX
IRIX
TSBK
TSBK
Q4 25
$8.2M
Q3 25
$-1.6M
$8.4M
Q2 25
$-994.0K
$7.1M
Q1 25
$-1.7M
$6.8M
Q4 24
$-834.0K
$6.9M
Q3 24
$-1.9M
$6.4M
Q2 24
$-2.7M
$5.9M
Q1 24
$-3.5M
$5.7M
Gross Margin
IRIX
IRIX
TSBK
TSBK
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
TSBK
TSBK
Q4 25
Q3 25
-11.3%
Q2 25
-6.9%
Q1 25
-1.7%
Q4 24
-3.9%
Q3 24
-16.1%
Q2 24
-20.9%
Q1 24
-28.0%
Net Margin
IRIX
IRIX
TSBK
TSBK
Q4 25
37.8%
Q3 25
-12.6%
37.6%
Q2 25
-7.3%
34.6%
Q1 25
-14.2%
33.9%
Q4 24
-6.6%
34.9%
Q3 24
-16.7%
32.6%
Q2 24
-21.2%
31.6%
Q1 24
-29.5%
31.3%
EPS (diluted)
IRIX
IRIX
TSBK
TSBK
Q4 25
$1.04
Q3 25
$-0.09
$1.06
Q2 25
$-0.06
$0.90
Q1 25
$-0.10
$0.85
Q4 24
$-0.05
$0.86
Q3 24
$-0.12
$0.80
Q2 24
$-0.16
$0.74
Q1 24
$-0.21
$0.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
TSBK
TSBK
Cash + ST InvestmentsLiquidity on hand
$6.0M
$246.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$268.4M
Total Assets
$29.2M
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
TSBK
TSBK
Q4 25
$6.0M
$246.9M
Q3 25
$5.6M
$243.4M
Q2 25
$6.8M
$193.6M
Q1 25
$7.2M
$191.2M
Q4 24
$2.4M
$164.1M
Q3 24
$3.9M
$164.7M
Q2 24
$4.1M
$158.9M
Q1 24
$5.4M
$180.3M
Total Debt
IRIX
IRIX
TSBK
TSBK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
TSBK
TSBK
Q4 25
$268.4M
Q3 25
$4.7M
$262.6M
Q2 25
$6.1M
$256.7M
Q1 25
$852.0K
$252.5M
Q4 24
$2.1M
$249.2M
Q3 24
$2.6M
$245.4M
Q2 24
$4.2M
$241.2M
Q1 24
$6.5M
$238.7M
Total Assets
IRIX
IRIX
TSBK
TSBK
Q4 25
$29.2M
$2.0B
Q3 25
$28.4M
$2.0B
Q2 25
$31.6M
$2.0B
Q1 25
$34.2M
$1.9B
Q4 24
$29.1M
$1.9B
Q3 24
$30.2M
$1.9B
Q2 24
$31.2M
$1.9B
Q1 24
$34.1M
$1.9B
Debt / Equity
IRIX
IRIX
TSBK
TSBK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
TSBK
TSBK
Operating Cash FlowLast quarter
$6.1M
Free Cash FlowOCF − Capex
$5.6M
FCF MarginFCF / Revenue
25.7%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
0.74×
TTM Free Cash FlowTrailing 4 quarters
$56.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
TSBK
TSBK
Q4 25
$6.1M
Q3 25
$-1.2M
$30.2M
Q2 25
$-397.0K
$10.8M
Q1 25
$-1.1M
$12.4M
Q4 24
$-1.2M
$-3.1M
Q3 24
$-3.1M
$23.0M
Q2 24
$-1.3M
$7.4M
Q1 24
$-1.6M
$4.1M
Free Cash Flow
IRIX
IRIX
TSBK
TSBK
Q4 25
$5.6M
Q3 25
$-1.2M
$28.4M
Q2 25
$-410.0K
$10.3M
Q1 25
$-1.2M
$12.2M
Q4 24
$-1.2M
$-3.6M
Q3 24
$-3.1M
$21.7M
Q2 24
$7.2M
Q1 24
$-1.7M
$3.6M
FCF Margin
IRIX
IRIX
TSBK
TSBK
Q4 25
25.7%
Q3 25
-9.4%
126.4%
Q2 25
-3.0%
50.5%
Q1 25
-9.8%
61.1%
Q4 24
-9.8%
-18.1%
Q3 24
-26.5%
111.5%
Q2 24
38.4%
Q1 24
-14.0%
19.8%
Capex Intensity
IRIX
IRIX
TSBK
TSBK
Q4 25
2.3%
Q3 25
0.1%
7.7%
Q2 25
0.1%
2.1%
Q1 25
0.1%
1.0%
Q4 24
0.1%
2.6%
Q3 24
0.0%
6.7%
Q2 24
0.0%
1.1%
Q1 24
0.0%
2.7%
Cash Conversion
IRIX
IRIX
TSBK
TSBK
Q4 25
0.74×
Q3 25
3.57×
Q2 25
1.52×
Q1 25
1.83×
Q4 24
-0.45×
Q3 24
3.62×
Q2 24
1.25×
Q1 24
0.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons